The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
MicroRNAs 103 and 107 regulate insulin sensitivity
Open accessAbstract
Defects in insulin signalling are among the most common and earliest defects that predispose an individual to the development of type 2 diabetes. MicroRNAs have been identified as a new class of regulatory molecules that influence many biological functions, including metabolism. However, the direct regulation of insulin sensitivity by microRNAs in vivo has not been demonstrated. Here we show that the expression of microRNAs 103 and 107 (miR-103/107) is upregulated in obese mice. Silencing of miR-103/107 leads to improved glucose homeostasis and insulin sensitivity. In contrast, gain of miR-103/107 function in either liver or fat is sufficient to induce impaired glucose homeostasis. We identify caveolin-1, a critical regulator of the insulin receptor, as a direct target gene of miR-103/107. We demonstrate that caveolin-1 is upregulated upon miR-103/107 inactivation in adipocytes and that this is concomitant with stabilization of the insulin receptor, enhanced insulin signalling, decreased adipocyte size and enhanced insulin-stimulated glucose uptake. These findings demonstrate the central importance of miR-103/107 to insulin sensitivity and identify a new target for the treatment of type 2 diabetes and obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“MicroRNA inhibitors (antagomirs) targeting miR-103 and miR-107 improve insulin sensitivity and reduce adiposity in diet-induced obese mice by enhancing hepatic and peripheral insulin signaling [92].”
From Obesity: Clinical Impact, Pathophysiology, Complications, and Modern Innovations in Therapeutic Strategies (2025) · cites this paper as [92]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
Self-citationCritical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760
Caveolin, a protein component of caveolae membrane coats
Rothberg, K. G., Heuser, J. E., Donzell, W. C., Ying, Y., Glenney, J. R., & Anderson, R. G. W. (1992) · Cell · doi:10.1016/0092-8674(92)90143-z · Cited by 2,259
Rational design of cationic lipids for siRNA delivery
Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822
The multiple faces of caveolae
Parton, R. G., & Simons, K. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2122 · Cited by 1,529
Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes
Muoio, D. M., & Newgard, C. B. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2327 · Cited by 1,177
MicroRNA-143 Regulates Adipocyte Differentiation
Esau, C., Kang, X., Peralta, E. R., Hanson, E. M., Marcusson, E. G., Ravichandran, L. V., Sun, Y., Koo, S., Perera, R. J., Jain, R., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400438200 · Cited by 1,023
The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance
Goossens, G. H. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.10.010 · Cited by 591
Flagged first, then by citations
Cited by
Sorted by citations
Items 901–996 of 996
Role of Non-coding RNAs in Vascular Complications of Diabetes Mellitus
Surendran, S., & Kartha, C. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-60324-7_15 · Cited by 1
microRNAs in Nutritional Signaling and Metabolic Syndrome
Wade, H., & Su, Q. (2019) · Elsevier eBooks · doi:10.1016/b978-0-08-100596-5.22723-6 · Cited by 1
Li, X., & Kong, Q. (2020) · PubMed Central · doi:10.7507/1002-1892.201912092 · Cited by 1
Yu, C., Chen, J., & Ren, J. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07503-0 · Cited by 1
Regazzi, R. (2013) · Wiley eBooks · doi:10.1002/9781118300312.ch30 · Cited by 1
Expressão de microRNAs circulantes relacionados ao diabetes tipo 1 autoimune
Santos, A. S. (2018) · doi:10.11606/t.5.2018.tde-14082018-124100 · Cited by 1
Oluwadare, E. O. (2026) · Research Output (Edinburgh Napier University) · doi:10.17869/enu.1036075 · Cited by 1
Krause, C., Britsemmer, J. H., Bernecker, M., Molenaar, A., Taege, N., Geißler, C., Kaehler, M., Iben, K., Judycka, A., Wagner, J., et al. (2023) · doi:10.7554/elife.92075.1 · Cited by 1
Abedi, Z., Salehi, Z., Zaersabet, M., Sojoudi, K., Mashayekhi, F., & Motamed, B. (2024) · Research Square · doi:10.21203/rs.3.rs-3753374/v1 · Cited by 1
MicroRNAs in Obesity and Metabolism
Sousa-Ferreira, L., de Almeida, L. P., & Cavadas, C. (2014) · Springer eBooks · doi:10.1007/978-3-319-12766-8_9
Probing microRNA Activity in vitro and inside Cells using Single Molecule Microscopy.
Pitchiaya, S. (2012) · Deep Blue (University of Michigan)
Bai, H. (2012) · InTech eBooks · doi:10.5772/49945 · Cited by 1
Multifunctional Polymeric Nanosystems for RNA Interference Therapy
Iyer, A. K., Ganesh, S., Zhou, Q. L., & Amiji, M. M. (2013) · Pharmaceutical Sciences Encyclopedia · doi:10.1002/9780470571224.pse517
MicroRNA-mediated regulation of Cadm1 contributes to beta cell function and energy homeostasis
Rathjen, T. (2015) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-6345
Circulating Nucleic Acids and Diabetes Mellitus
Butt, A., & Swaminathan, R. (2014) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-94-017-9168-7_9
The Role of miRNAs Playing in Human Cancers Chemosensitivity
Xuan, L. A. Z. (2014) · Biochemistry & Pharmacology Open Access · doi:10.4172/2167-0501.1000133
Epigenetics: An Intermediary of Environmental Regulation of
Pietrzykowski, Z. (2014)
MicroRNA and Diabetes Mellitus
Salö, S., Geiger, J., Sørensen, A. E., & Dalgaard, L. T. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801585-8.00021-x
Les micro-ARNs et le diabète de type 2 : ce qu’il faut retenir
Cauchi, S. (2016) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(16)30086-4
Moisá, S. J. (2015) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Role of microRNA-709 in murine liver
Surendran, S. (2014) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1957
Identification of microRNAs as potential novel regulators of HSD11B1 expression
Han, Y. (2012) · Multimedialen Archiv und Publikationsserver der Christian-Albrechts-Universität zu Kiel (Christian-Albrechts-Universität zu Kiel)
The Biochemical Cascades of the Human Pancreatic β-Cells: The Role of MicroRNAs
Kim, J. W., & Luo, J. Z. Q. (2015) · Journal of Bioanalysis & Biomedicine · doi:10.4172/1948-593x.1000e133
Expresión de PPAR-γ y miR-27 en el tejido adiposo de pacientes obesos
Triana, J. L. T. (2015) · doi:10.14201/gredos.127896
MicroRNAs in Diabetes and Its Vascular Complications
Shantikumar, S., Rovira‐Llopis, S., Spinetti, G., & Emanueli, C. (2017) · Cardiac and vascular biology · doi:10.1007/978-3-319-52945-5_3
WITHDRAWN: Epigenetics in Chronic Liver Disease
Boyle, M., & Mann, J. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.08.016
RetractedChu, W. H. (2018) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Potential of Polyphenols as Therapeutic Options in Type 2 Diabetes
Nasrabadi, E. N. (2018) · Griffith Research Online · doi:10.25904/1912/3203
Divergent Transcriptional Regulation of Suppressors of Cytokine Signaling Genes in Adipocytes
de Sa, P. M. (2019) · Louisiana State University · doi:10.31390/gradschool_dissertations.4982
Epigenetics and Chronic Inflammation: Role in Early Detection of Type 2 Diabetes
Ghai, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-53370-0_18
Вплив пробіотичного харчування при цукровому діабеті 2 типу
Fadieienko, G. D., & Kurinna, O. G. (2020) · doi:10.30978/utj2020-2-43
Zhang, D., Niu, S.-Z., Ma, Y., Zhou, B., Deng, Y., Geng, Z.-T., Wen, Y., Luo, S., Shi, C., Pu, G., et al. (2020) · doi:10.21203/rs.3.rs-83279/v1
Velmurugan, G. V., Ly, H., Sharma, S., Verma, N., Despa, S. I., Nelson, P. T., Goldstein, L. B., & Despa, F. (2020) · doi:10.21203/rs.3.rs-52604/v1
Metabolic rewiring of the failing heart
Kuhn, A.-R. (2021) · doi:10.26481/dis.20211118ak
Mayo, O. (2012) · InTech eBooks · doi:10.5772/35070
Song, S., Li, X., Geng, C., Guo, Y., & Wang, C. (2022) · Research Square · doi:10.21203/rs.3.rs-1400164/v1
Emerging Therapeutic Targets for Diabetes
(2016) · CRC Press eBooks · doi:10.1201/9781315370118-4
Post-transcriptional gene regulation in metabolic syndrome
Pathak, R., & Kumar, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91305-8.00003-x · Cited by 1
Role of microRNAs in tumor progression among Iranian population: An overview
Rahmani, Z., Taghehchian, N., Navaei, Z. N., & Moghbeli, M. (2022) · Human Gene · doi:10.1016/j.humgen.2022.201120
The Host–Helminth Interface as a Rich Resource for Novel Drug Targets
Duguet, T. B., & Tritten, L. (2022) · Wiley eBooks · doi:10.1002/9783527823413.ch19
microRNA: Sebuah panduan pemula untuk klinisi dan peneliti
Sanjaya, A. (2023) · Journal Of Medicine & Health · doi:10.28932/jmh.v5i1.3540
MicroRNAs in Liver Regeneration
Yang, D., Möbus, S., Balakrishnan, A., & Sharma, A. D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-820719-2.00026-0
Krause, C., Britsemmer, J. H., Bernecker, M., Molenaar, A., Taege, N., López‐Alcántara, N., Geißler, C., Kaehler, M., Iben, K., Judycka, A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.02.560594
何, 星. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.13112442
New Therapeutic Chemical Modalities: Compositions, Modes-of-action, and Drug Discovery
Valeur, E. (2023) · Royal Society of Chemistry eBooks · doi:10.1039/9781788018982-00911
Krause, C., Britsemmer, J. H., Bernecker, M., Molenaar, A., Taege, N., López‐Alcántara, N., Geißler, C., Kaehler, M., Iben, K., Judycka, A., et al. (2024) · doi:10.7554/elife.92075.2
Managing autoimmune disorders through personalized epigenetic approaches
Telatin, M., & Chang, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23802-4.00029-6
Jia, X., Liu, J., Jiang, W., Chang, L., Shen, X., Jiang, G., Li, X., Chi, C., Liu, W., & Zhang, D. (2024) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2024.111763
Association of miRNA451a with Insulin Resistance and Diabetes Kidney Disease
张, 芷. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.14112955
Bioinformatics for the Identification of STING-Related Genes in Diabetic Retinopathy
Wang, Y., Liu, S., Zhou, Q., Feng, Y., Xu, Q., Luo, L., & Lv, H. (2024) · Current Eye Research · doi:10.1080/02713683.2024.2430223
Yu, J., Xia, K., Feng, J., Xu, Z., Zhang, Z., Xiao, G., Zhu, H., Xue, W., Chen, F., & Xie, X. (2025) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s533519 · Cited by 1
Santilli, F., & Simeone, P. (2025) · Springer eBooks · doi:10.1007/978-3-031-96352-0_7
The Crosstalk Between Non-Coding RNAs and Lipid Metabolism in Chronic Disease Progression
Zayani, Z., Matinahmadi, A., Tavakolpournegari, A., Moosavi, S. S., & Bidooki, S. H. (2025) · Lipidology · doi:10.3390/lipidology2040019
Micro-RNA prediction tools and target analysis
Tiwari, A., & Sharma, R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21980-1.00011-5
Impact of metabolic perturbation on ovarian function
Nteeba, J. (2014) · doi:10.31274/etd-180810-401
Islam, A. B. M. M. K., Mohammad, E., & Khan, M. A.-A.-K. (2020) · Figshare · doi:10.6084/m9.figshare.13023731
Islam, A. B. M. M. K., Mohammad, E., & Khan, M. A.-A.-K. (2020) · Figshare · doi:10.6084/m9.figshare.13023734
Islam, A. B. M. M. K., Mohammad, E., & Khan, M. A.-A.-K. (2020) · Figshare · doi:10.6084/m9.figshare.13023737
Islam, A. B. M. M. K., Mohammad, E., & Khan, M. A.-A.-K. (2020) · Figshare · doi:10.6084/m9.figshare.13023728
Lin, H.-Z., Liang, Z.-K., Huang, J.-J., Yang, Y., Huang, Y., Wu, Z.-S., Tan, J.-L., Huang, S. J., Ruan, S.-H., Xu, B.-Y., et al. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02829-z
The Role of Exosomes in Metabolic Syndrome and Cell Therapy
Shiomi, N., Zhang, P., Matsuyama, K. K. A. H., & Matsuyama, H. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1013554
Ermakova, D. L., Rakhmonova, F. S., & Dolgushina, N. V. (2026) · GYNECOLOGY · doi:10.26442/20795696.2026.1.203566
Rudhra, O., & Singh, S. K. (2026) · Research Square · doi:10.21203/rs.3.rs-9067110/v1
Herrera, C. L. (2015) · theses.fr (ABES) · doi:10.70675/d09d7e9cz079fz4faaz985aza9cd4fc18f18
Identification de marqueurs de susceptibilité dans les formes chroniques de la maladie de Chagas
Laugier, L. (2017) · theses.fr (ABES) · doi:10.70675/2d7f9c97z09c9z4593z8a61z974cc7d5a1c0
Wassaifi, S., Rahali, N., Finsterer, J., Lahidheb, D., Kaeffer, B., & Zarrouk‐Mahjoub, S. (2026) · Clinical and Translational Discovery · doi:10.1002/ctd2.70115
Sportiello, P., Piccioni, M., Licciulli, F., Cananzi, G., Crispi, S., & Catalano, D. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27094134 · Cited by 1
Cardiovascular Dysfunction in Type 2 Diabetes: The Role of MicroRNAs
Kayki‐Mutlu, G., & Arioglu-Inan, E. (2026) · Handbook of experimental pharmacology · doi:10.1007/164_2026_799
Wang, J., Zhang, P., Hu, G., Chen, D., Huang, Y., Zou, K., Ye, R., Cao, X., Zhang, Q., Li, Y., et al. (2026) · Small Methods · doi:10.1002/smtd.70720
miRNA-Based Therapies: From Cell to Clinic
Pardo, V., Frutos, M. F.-D., López-Aceituno, J. L., & Ramírez, C. M. (2025) · Springer handbooks · doi:10.1007/978-3-032-01636-2_18
Phase-dependent reorganization of circulating miRNA networks following short maximal exercise
Dytrtová, J. J., Jakl, M., Moravek, O., Smělá, D., Bílková, Z., Navrátil, T., Baber, F., Maleček, J., & Korecká, L. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1852791
Valenzise, M., Drago, S. F. A., Polito, F., Salzano, G., Gasparo, I., Khouyyi, M., Licitri, L., Mirabello, A. M., Romano, S., Mottola, V., et al. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2026.1851386
Choi, S. A., & Hong, S.-H. (2026) · Genes & Genomics · doi:10.1007/s13258-026-01781-9
Genetic and epigenetic landscape of type 2 diabetes mellitus
Patil, P. C., Surve, S., Kaleem, M., Bachhav, R. S., & Kayali, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33590-7.00012-5
MicroRNA: role in pathogenesis, problems of microRNA therapy, and future prospects
Kugaevskaya, E. V., Timoshenko, O. S., Gureeva, T. A., & Lisitsa, A. V. (2026) · Biomeditsinskaya Khimiya · doi:10.18097/pbmcr1705
Lino, M., Ruiz, G. P., Efthymiou, V., Rodrigues, A. C., Bhonsle, S., Nawaz, A., Ghosh, A., Brandão, B. B., Watanabe, Y., Salgueiro, R. B., et al. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01558-0
RNA-based approaches in the diagnosis and treatment of obesity
Parekh, K., & Sarker, G. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1882300
Wang, J., Zhu, J., Zhu, C., Zan, X., Zhou, H., Zhi, Y., Liu, S., Liu, J., Zhu, M., Wang, J., et al. (2026) · Food & Function · doi:10.1039/d6fo02284g
Eliasson, L., Karagiannopoulos, A., Nagao, M., & Wendt, A. (2026) · Acta Physiologica · doi:10.1111/apha.70288
Motiee, S., Tayebinia, H., Jalilian, N., Ghorbani, Z., & Mohagheghi, S. (2026) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2026.102763
Gil‐Lozano, M., Simoes, E., Wu, M., Wiedemann, T., 권윤, Sekar, R., Morigny, P., Troullinaki, M., Merl‐Pham, J., Buettner, M., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-77808-2
Haq, A. T. A., Yang, P.-P., Shen, P.-C., Tseng, H., Chen, L.-M., Chen, M. A., Yuh, C.-H., & Hsu, H.-L. (2026) · Research Square · doi:10.21203/rs.3.rs-10952514/v1
Zhou, L., Ke, J., Zhang, S., Xiao, S., Zhang, H., Liu, S., Liu, L., Liu, M., Lu, Z., & Zheng, S. G. (2026) · Cancer Biology & Therapy · doi:10.1080/15384047.2026.2725357
Jia, J., Shen, L., Lin, X., 韩, 留., Huang, S., Bai, B., Li, Y., Hong, G., Zhao, P., Chen, L., et al. (2026) · Life Sciences · doi:10.1016/j.lfs.2026.124714
Kaymaz, T. (2026) · Turkish Journal of Science and Technology · doi:10.55525/tjst.1989356
Kim, Z., Ha, E. Y., & Park, J. (2026) · Biomolecules · doi:10.3390/biom16101472
Multifaceted role of genetic and epigenetic architecture of glucose homeostasis and diabetes
Khokhar, M. (2026) · npj Metabolic Health and Disease · doi:10.1038/s44324-026-00135-z
circGDI2 promotes epithelial IL-33 release and allergic airway inflammation in asthma
Abuduxukuer, Z., Zhu, L., Li, D., Zhu, G., Zeng, Y., Chen, Y., Mo, Y., Cai, H., Song, Y., Liang, Y., et al. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117570
Epigenetic Epidemiology of Obesity, Type 2 Diabetes, and Metabolic Disorders
Stöger, R. J. (2011) · Springer eBooks · doi:10.1007/978-94-007-2495-2_20
Metadata
- Authors
- Trajkovski, M., Hausser, J., Soutschek, J., Bhat, B., Akin, A., Zavolan, M., Heim, M. H., & Stoffel, M.
- Affiliations
- ETH Zurich (CH)
- University of Basel (CH)
- Regulus Therapeutics (United States) (US)
- University Hospital of Basel (CH)
- Corresponding author
- Stoffel, Markus
- Venue
- Nature
- Published
- 2011-06
- Volume
- 474
- Issue
- 7353
- Pages
- 649-653
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2075317528
- Cited by
- 1,000
- References
- 27
- Citations by year
- 2026: 36 · 2025: 34 · 2024: 54 · 2023: 45 · 2022: 61 · 2021: 61 · 2020: 71 · 2019: 68 · 2018: 80 · 2017: 65 · 2016: 98 · 2015: 90 · 2014: 90 · 2013: 77 · 2012: 57
- FWCI
- 25.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- BIROn (Birkbeck, University of London) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- National Science Foundation
- Juvenile Diabetes Research Foundation International
- Fondation Leducq
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- microRNA-107, insulin sensitivity, caveolin-1, insulin signaling, insulin receptor, glucose homeostasis, obesity, type 2 diabetes, adipocytes, liver, insulin-stimulated glucose uptake, adipocyte size, miRNA target genes
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Disease Models, Animal, Gene Expression Regulation, Glucose, Homeostasis, Hyperglycemia, Insulin, Liver, Male, Mice, Inbred C57BL, Signal Transduction, Up-Regulation, Gene Expression, Adipocytes, Gene Silencing, MicroRNAs, Cell Size, Caveolin 1, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
